Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
EV/Core EBITDA

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 53.10-6.07-4.82

What is the latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA ?

The latest EV/Core EBITDA ratio of ONESOURCE SPECIALTY PHARMA is 53.10 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202553.10
Mar2024-6.07
Mar2023-4.82

How is EV/Core EBITDA of ONESOURCE SPECIALTY PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 53.1
Positive
Mar2024 -6.07
Negative
Mar2023 -4.82 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare EV/Core EBITDA ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹20,034.9 Cr -3.9% 19.3% 9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 5.2% 3.8% -1.8% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 2.2% 11.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 0.8% 0.7% 25.7% Stock Analytics
CIPLA ₹107,722.0 Cr 1.3% 9.1% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -3.5% 2.7% 10.3% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

-3.9%

19.3%

9.1%

SENSEX

0.8%

5%

-2.5%


You may also like the below Video Courses